Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05830942

Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults

Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Declines in cognitive function and walking function are highly intertwined in older adults. A therapeutic approach that combines complex (cognitively engaging) aerobic walking exercise with non-invasive electrical brain stimulation may be effective at restoring lost function. This study tests whether electrical stimulation of prefrontal brain regions is more beneficial than sham stimulation.

Detailed description

Efficacy of transcranial direct current stimulation (tDCS) combined with complex (cognitively engaging) walking exercise in older adults. The primary outcome measures are executive function (computer-based assessment battery) and complex walking function (speed on an obstacle negotiation task). This will be a two-site trial conducted at the University of Florida (lead site) and Brooks Rehabilitation Hospital, which is necessary to achieve enrollment targets and will allow us to develop a multi-site research infrastructure for a future Phase 3 multi-site trial. The study will enroll up to 120 older adult women and men, who exhibit mild to moderate decline of executive function. All experimental groups will receive the same complex walking intervention, which will focus on use of cognitively engaging tasks such as obstacle crossing, accurate foot placement, and walking on complaint surfaces. Each session will consist of 30 minutes of walking. For tDCS, the active treatment group will receive 20 minutes of 2mA tDCS over prefrontal regions F3/F4 ("treatment group"). The second group is a sham control group. tDCS will be delivered simultaneously with complex walking exercise for 18 sessions over a 6-week period. Assessments will be conducted at baseline, post intervention (within one week), and 12 weeks post-intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWalking Exerciseaerobic walking exercise using complex (cognitively engaging) walking tasks
DEVICEPrefrontal Active tDCS20 minutes of 2 milliamp transcranial direct current stimulation (tDCS) of prefrontal regions, delivered at each session
DEVICEPrefrontal Sham tDCS30 seconds of 2 milliamp transcranial direct current stimulation (tDCS) of prefrontal regions, delivered at each session

Timeline

Start date
2024-04-15
Primary completion
2027-04-30
Completion
2027-04-30
First posted
2023-04-26
Last updated
2025-05-08

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05830942. Inclusion in this directory is not an endorsement.